These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20008092)

  • 21. A Case of Anti-PD-L1-associated Remitting Seronegative Symmetric Synovitis With Pitting Edema.
    Redman JM; Rhea LP; Cordes L; Owens H; Madan RA; Bilusic M; Gulley JL; Lee JM; Dahut WL; Karzai F
    Clin Genitourin Cancer; 2019 Jun; 17(3):e549-e552. PubMed ID: 30850338
    [No Abstract]   [Full Text] [Related]  

  • 22. Parvovirus B19: another agent associated with remitting seronegative symmetrical synovitis with pitting edema.
    Perandones CE; Colmegna I; Arana RM
    J Rheumatol; 2005 Feb; 32(2):389-90. PubMed ID: 15693107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pitting edema of the four extremities of rapid appearance.
    Coiteux I; Depairon M; Hayoz D
    Vasa; 2005 May; 34(2):144-6. PubMed ID: 15968900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remitting seronegative symmetrical synovitis with pitting edema.
    Sekhon L
    JAAPA; 2010 Feb; 23(2):38, 40, 43. PubMed ID: 20214247
    [No Abstract]   [Full Text] [Related]  

  • 25. Remitting symmetric seronegative synovitis with pitting edema (RS3PE) secondary to non-Hodgkin's lymphoma.
    Goldenberg K; Rozenbaum M; Rosner I; Naschitz J; Kotler C
    Clin Exp Rheumatol; 1998; 16(6):767-8. PubMed ID: 9844786
    [No Abstract]   [Full Text] [Related]  

  • 26. [The remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome].
    Bonapart IE; van Paassen HC; Wouters JM
    Ned Tijdschr Geneeskd; 1996 Jul; 140(29):1512-4. PubMed ID: 8765938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hope for chronic inflammatory diseases : the anti-IL-6 receptor monoclonal antibody tocilizumab].
    Spertini F
    Rev Med Suisse; 2017 Jan; 13(544-545):20-22. PubMed ID: 28703529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remitting seronegative symmetrical synovitis with pitting edema: an adult case with excellent prognosis.
    Ozoran K; Ataman S; Aydintuğ O; Tülek N; Düzgün N
    Rheumatol Int; 1994; 13(5):215-6. PubMed ID: 8202666
    [No Abstract]   [Full Text] [Related]  

  • 29. Interleukin-6 as a key player in systemic inflammation and joint destruction.
    Fonseca JE; Santos MJ; Canhão H; Choy E
    Autoimmun Rev; 2009 Jun; 8(7):538-42. PubMed ID: 19189867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis.
    Okuda Y; Takasugi K
    Arthritis Rheum; 2006 Sep; 54(9):2997-3000. PubMed ID: 16947531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease.
    Kawabata H; Tomosugi N; Kanda J; Tanaka Y; Yoshizaki K; Uchiyama T
    Haematologica; 2007 Jun; 92(6):857-8. PubMed ID: 17550864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical benefits of anti-human IL-6 receptor antibody therapy].
    Nishimoto N
    Clin Calcium; 2007 Apr; 17(4):562-8. PubMed ID: 17404486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Humanized anti-human IL-6 receptor antibody, tocilizumab].
    Nishimoto N
    Nihon Rinsho; 2007 Jul; 65(7):1218-25. PubMed ID: 17642235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome following spontaneous rupture of a gouty tophus.
    Sugisaki K; Hirose T
    Mod Rheumatol; 2008; 18(6):630-3. PubMed ID: 18688694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tocilizumab for rheumatoid and juvenile idiopathic arthritis.
    Bongartz T
    Lancet; 2008 Mar; 371(9617):961-3. PubMed ID: 18358909
    [No Abstract]   [Full Text] [Related]  

  • 36. Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy.
    Yamamoto S; Fujita S; Mukai T; Sawachika H; Morita Y
    Intern Med; 2020 Feb; 59(4):599. PubMed ID: 31666472
    [No Abstract]   [Full Text] [Related]  

  • 37. Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy.
    Yamamoto S; Fujita S; Mukai T; Sawachika H; Morita Y
    Intern Med; 2020 Feb; 59(4):597-598. PubMed ID: 31666471
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tocilizumab in rheumatoid arthritis. Interleukin 6 as a new target].
    Heinzl S
    Med Monatsschr Pharm; 2008 Dec; 31(12):450-3. PubMed ID: 19133593
    [No Abstract]   [Full Text] [Related]  

  • 39. Interleukin-6: a new therapeutic target.
    Smolen JS; Maini RN
    Arthritis Res Ther; 2006; 8 Suppl 2(Suppl 2):S5. PubMed ID: 16899109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tocilizumab (Actemra) for giant cell arteritis.
    Med Lett Drugs Ther; 2017 Sep; 59(1530):161-162. PubMed ID: 28922343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.